Shimon Peres to Advise Teva PharmaceuticalsConsulting job to the tune of $10,000 per month reportedly on the table; details have not been finalized.
Israeli Pharma Teva Looks to Become Global Giant$40 billion acquisition of US company would launch Teva to unprecedented size - but will its bid be accepted?
Pharmaceutical Giant Teva's Chairman to ResignChairman Phillip Frost's announcement the latest in a string of abrupt changes in major Israeli company.
Teva Setback: Competitors Can Sell CopaxoneA U.S. Supreme Court Justice gave a green light for competitors of Teva to sell generic versions of multiple sclerosis drug Copaxone.
Erez Vigodman Named New Teva CEOTeva on Thursday named Erez Vigodman, 54, as new CEO of the company, after last October's controversial resignation of Dr. Jeremy Levin.
Pfizer Settles with Teva on Generic ViagraTeva will pay Pfizer a royalty for a license to produce its generic version, from late 2017.
Teva Brings 'Captive Profits' Home, Gets Tax BreakTeva said Monday that it would return tens billions of shekels to Israel from abroad, and pay a tax bill of nearly three billion shekels.
CEO of Teva Pharmaceuticals Steps DownJeremy Levin resigns from the pharmaceutical giant amid tensions in the company
Teva: Layoffs Will be Coordinated with HistadrutAfter meeting with Histadrut chairman, pharmaceutical giant promises it will coordinate layoff plans.
Lapid 'Dissatisfied' with Teva LayoffsFinance Minister says he has spoken to Teva's CEO and asked him to reduce the number of employees the company lays off.
Teva Laying Off 5,000 EmployeesPharmaceutical firm will reduce global manpower by 10%; 700-800 layoffs expected in Israel.
American Jew to Head TevaAmerican Jew Dr. Jeremy Levin was named new CEO for Teva Pharmaceuticals Monday, when Shlomo Yanai announced he is stepping down.
Former CEO of Teva Pharmaceuticals Dies at 79Eli Hurvitz, who served as CEO of Teva Pharmaceutical Industries until 2002, passes away from a serious illness.
Israeli Drug: No More Insulin Injections?Two Israeli-based firms try out a peptide aimed at stopping Type 1 diabetes at its source and eliminate the need for insulin injections.
New Lymphoma Cure Passes Phase 2A new treatment for lymphoma, a type of cancer, has passed its Phase II clinical trial. CT-011 is produced by CureTech, a Teva company.
Teva Appeals Whopping US VerdictIsrael’s Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, has dedicated its new, $100 million distribution center.
Teva Drugs Approved by FDATeva Pharmaceuticals enjoys the approval of two new generics by the US Food and Drug Administration, stocks rise.
Teva Acquires German RatiopharmIsraeli pharmaceutical giant Teva has won the bid to acquire German generic drug maker Ratiopharm for $4.9 billion.
TEVA’s Rx for InvestorsIsraeli-based TEVA has been called a juggernaut, copy-cat and an 800-pound ape. It makes generic drugs, lots of them, and money – lots of it.
Teva Partners on Cancer DrugIsraeli pharmaceutical giant Teva has signed a deal to invest $60 million in a new cancer-fighting drug to fight prostate and lung cancer.